psilocybin has been researched along with Affective Psychosis, Bipolar in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashtari, A; DellaCrosse, M; Michalak, E; Morton, E; Pleet, M; Sakai, K; Woolley, J | 1 |
| Chakrabarty, T; DuBois, A; Keramatian, K; Saraf, G; Yatham, LN | 1 |
| Hendin, HM; Penn, AD | 1 |
| PELICIER, Y | 1 |
| Rysánek, K | 1 |
2 review(s) available for psilocybin and Affective Psychosis, Bipolar
| Article | Year |
|---|---|
New Pharmacologic Approaches to the Treatment of Bipolar Depression.
Topics: Antidepressive Agents; Bipolar Disorder; Depression; Humans; Ketamine; Psilocybin; Randomized Controlled Trials as Topic; Treatment Outcome | 2023 |
[Relation of monoamines to mental disorders].
Topics: Amines; Animals; Bipolar Disorder; Catecholamines; Central Nervous System; Depression; Dihydroxyphenylalanine; Dopamine; Epinephrine; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Disorders; Methylation; Monoamine Oxidase Inhibitors; Phenethylamines; Psilocybin; Reserpine; Schizophrenia; Serotonin; Tryptamines | 1970 |
3 other study(ies) available for psilocybin and Affective Psychosis, Bipolar
| Article | Year |
|---|---|
"A sense of the bigger picture:" A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use.
Topics: Adult; Bipolar Disorder; Follow-Up Studies; Humans; Mania; Psilocybin; Quality of Life; Self Report | 2022 |
An episode of mania following self-reported ingestion of psilocybin mushrooms in a woman previously not diagnosed with bipolar disorder: A case report.
Topics: Agaricales; Bipolar Disorder; Eating; Female; Humans; Mania; Psilocybin; Self Report | 2021 |
[SEROTONIN AND PSYCHIATRY].
Topics: Bipolar Disorder; Catecholamines; Drug Therapy; Hallucinations; Hallucinogens; Humans; Hydroxyindoleacetic Acid; Hypoglycemic Agents; Indoleacetic Acids; Lysergic Acid Diethylamide; Mescaline; Metabolism; Monoamine Oxidase Inhibitors; Phenothiazines; Psilocybin; Psychiatry; Psychotic Disorders; Research; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin | 1964 |